CIK 0001680581 · Non-accelerated filer<br>Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474839948
- Phone
- 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-24 | Oltmans Curtis Gale Chief Legal Officer | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2024-11-12 | King Rachel K. Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-08-21 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Other disposition | −8,500,000 | 3,109,704 | ||
| 2024-08-21 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Other acquisition · Warrant (Right to Buy) | +8,500,000 | 8,500,000 | ||
| 2024-07-03 | Sapir Alex See Remarks | Option exercise | +150,000 | $3.27 | $491K | 193,360 |
| 2024-07-03 | Sapir Alex See Remarks | Option exercise · Stock option - Right to Buy | −150,000 | 2,280,400 | ||
| 2024-06-17 | Ezekowitz Alan Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Gould Robert J Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Haviland Kate Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Dorton Katina Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Collins James J. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Banks Sonja Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-06-17 | Hill Colin Director | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-05-07 | Tourangeau Greg Principal Accounting Officer | Sale | −236 | $7.76 | $2K | 11,571 |
| 2024-03-18 | Horn Patrick Taylor Chief Medical Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2024-03-08 | Tourangeau Greg Vice President, Finance | Sale | −4,884 | $11.72 | $57K | 11,807 |
| 2024-03-04 | Sapir Alex See Remarks | Purchase | +43,360 | $11.35 | $492K | 43,360 |
| 2024-01-26 | Tourangeau Greg Vice President, Finance | Grant or award · Stock Option (right to buy) | +83,820 | 83,820 | ||
| 2024-01-26 | Tourangeau Greg Vice President, Finance | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 3 of 7 · 136 trades